ArticleEndocrine1995
The regulation of uterine tissue factor by estrogen.
Article in Endocrine, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 5 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tissue factor (TF) is a transmembrane protein that initiates coagulation and indirectly catalyzes the conversion of prothrombin to thrombin. We previously showed that treatment of immature rats with estradiol (E(2)) stimulated a rapid increase in TF mRNA and protein in the uterus. Our current experiments usingin situ hybridization show that the increase in TF mRNA occurred primarily in the stromal cell layer. The effect of E(2) to increase TF mRNA occurred in uterine organ cultures but not in separated epithelial and stromal cellsin vitro. Thrombin and the phorbol ester, TPA, compounds which regulate TF expression in other cell types by activation of protein kinase C (PKC), increased TF mRNA in both uterine organ cultures and in separated uteriné cells. The 5' regulatory region of the TF gene was examined for the presence of an estrogen response element (ERE) using a plasmid, pTFCAT, containing -740 to + 15 bp of the mouse TF promoter upstream of the chloramphenicol acetyltransferase (CAT) reporter gene. There was no response to E(2) in HeLa cells cotransfected with pTFCAT and a human ER construct, pHEO. In contrast, E(2) increased CAT activity in cells cotransfected with a positive-control plasmid, containing the consensus ERE cloned upstream of the thymidine kinase promoter-driven CAT gene, and pHEO. CAT activity was also increased by TPA in cells transfected with pTFCAT. In summary, E(2) induces TF mRNA in uterine organ culture indicating that systemic factors are not absolutely required for the effect. However, E(2) injection induces transudation of plasma prothrombin into the uterus where it may be converted to thrombin. Thus thrombin may contribute to E(2)-induction of TF mRNAin vivo. An ERE was not identified in the 750 bp immediately 5' to the transcription start site of the TF gene although a TPA-responsive element was present. It is postulated that E(2) may induce TF mRNA by multiple indirect pathways including stimulation of PKC and Jun and Fos transcription factors, and by generation of thrombin in the uterus.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.